Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 12 Gastrointestinal 3 Plasma cell 2 Lymphoid 2 Sarcoma 1 CNS 1

Conditions

Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 73 Temozolomide 68 Specimen Handling 48 Radiotherapy 40 Radiosurgery 29 Bevacizumab 26 Radiation 25 Cyclophosphamide 25 Nivolumab 21 Biopsy 21 pembrolizumab 20 Carboplatin 16 X-Rays 14 Lomustine 13 Ipilimumab 13 fludarabine 12 Irinotecan 12 Vincristine 11 Topotecan 11 Surgical Procedures, Operative 11 Cisplatin 11 Blood Specimen Collection 11 trametinib 9 dinutuximab 9 Immunoglobulin G 8 Etoposide 8 Doxorubicin 8 lutetium Lu 177 dotatate 7 fludarabine phosphate 7 atezolizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

tucatinib × CNS × 90 days × Clear all

NCT05323955 2026-03-17

BRIDGET

Duke University

Phase 2 Active not recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡